loadpatents
name:-0.019800901412964
name:-0.014191865921021
name:-0.0023012161254883
Pradier; Laurent Patent Filings

Pradier; Laurent

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pradier; Laurent.The latest application filed is for "humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide".

Company Profile
1.15.15
  • Pradier; Laurent - Verrieres FR
  • PRADIER; Laurent - Paris FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20190119365 - Baurin; Nicolas ;   et al.
2019-04-25
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Grant 10,112,991 - Baurin , et al. October 30, 2
2018-10-30
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20160368977 - Baurin; Nicolas ;   et al.
2016-12-22
Pharmaceutical Composition For Use In The Treatment Of A Neurodegenerative Disease
App 20160354445 - HESS; Sibylle ;   et al.
2016-12-08
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Grant 9,382,312 - Baurin , et al. July 5, 2
2016-07-05
Pharmaceutical composition for use in the treatment of a neurodegenerative disease
Grant 9,364,519 - Hess , et al. June 14, 2
2016-06-14
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20140105890 - BAURIN; Nicolas ;   et al.
2014-04-17
Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
Grant 8,614,299 - Baurin , et al. December 24, 2
2013-12-24
Transgeneic animal expressing a multiple mutated form of presenilin 1
Grant 8,492,610 - Eckert , et al. July 23, 2
2013-07-23
Pharmaceutical Composition For Use In The Treatment Of A Neurodegenerative Disease
App 20130116179 - HESS; Sibylle ;   et al.
2013-05-09
Antibodies specific of the .beta.-amyloid peptides and their uses as diagnostic agents or drugs
Grant 8,343,493 - VanMechelen , et al. January 1, 2
2013-01-01
Nucleic acids encoding a human PAP1 polypeptide
Grant 8,273,548 - Koutnikova , et al. September 25, 2
2012-09-25
Humanized Antibodies Specific To The Protofibrillar Form Of The Beta-amyloid Peptide
App 20120177639 - Baurin; Nicolas ;   et al.
2012-07-12
Antibodies Specific Of The Beta-amyloid Peptides And Their Uses As Diagnostic Agents Or Drugs
App 20110059092 - Vanmechelen; Eugeen ;   et al.
2011-03-10
Method for detecting Alzheimer's disease
Grant 7,803,538 - Mace , et al. September 28, 2
2010-09-28
Transgenic animals exhibiting major disorders related to Alzheimer's disease
Grant 7,700,823 - Casas Louzao , et al. April 20, 2
2010-04-20
Compositions which can be used for regulating the activity of parkin
App 20060287230 - Koutnikova; Hana ;   et al.
2006-12-21
Compositions which can be used for regulating the activity of parkin
Grant 7,132,396 - Koutnikova , et al. November 7, 2
2006-11-07
Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein
Grant 7,070,940 - Corti , et al. July 4, 2
2006-07-04
Transgenic animals exhibiting major disorders related to Alzheimer's disease
App 20050076400 - Casas Louzao, Caty ;   et al.
2005-04-07
Method for detecting Alzheimer's disease
App 20050003417 - Mace, Sandrine ;   et al.
2005-01-06
Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)
App 20040224409 - Pradier, Laurent ;   et al.
2004-11-11
Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein
App 20040214763 - Corti, Olga ;   et al.
2004-10-28
Application of intestinal biliary acid reuptake inhibitors for the prevention and treatment of alzheimer's disease
App 20040138145 - Canton, Thierry ;   et al.
2004-07-15
Interaction test for the investigation of inhibitory molecules of the interaction between a presenilin and the .beta.-amyloid peptide
Grant 6,653,088 - Czech , et al. November 25, 2
2003-11-25
Compositions which can be used for regulating the activity of parkin
App 20020155577 - Koutnikova, Hana ;   et al.
2002-10-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed